FDA Announces Proposed Collection of Information for Human Blood and Blood Products Manufacturers

Summary

The Food and Drug Administration (FDA) has submitted a request for review and clearance from the Office of Management and Budget (OMB) for a proposed collection of information related to the registration and listing of human blood and blood products manufacturers and licensed devices, as mandated by the Paperwork Reduction Act of 1995.